Please login to the form below

Not currently logged in
Email:
Password:

psoriasis

This page shows the latest psoriasis news and features for those working in and with pharma, biotech and healthcare.

Novartis follows Pfizer and freezes US prices this year

Novartis follows Pfizer and freezes US prices this year

Novartis’decision to keep pricing steady has been helped by a rosy set of second-quarter results, with recent launches Cosentyx (secukinumab) for psoriasis and heart failure therapy Entresto (sacubitril and

Latest news

More from news
Approximately 60 fully matching, plus 243 partially matching documents found.

Latest Intelligence

  • Leo has its eyes on the prize Leo has its eyes on the prize

    Psoriasis and dermatitis may seem the same in everybody but maybe the picture is more like it is in cancer where you have subsets. ... Bridging the gap. Leo is tracking increases in atopic dermatitis across Europe while psoriasis levels show no signs of

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    costs. It was then backed with a ‘no response-no payment’contract. It has also struck novel reimbursement packages with its heart failure therapy Entresto and its psoriasis treatment Cosentyx.

  • Digital health Digital health

    In December 2016, Amalgam announced a partnership with UCB on a comprehensive behavioural and patient support programme for patients living with psoriasis. ... We went to the medical and behavioural literature to find out what has been shown to help

  • The good, the bad and the ugly The good, the bad and the ugly

    Elsewhere, Celgene has seen large growth in 2017 (46%) - driven by sales of Otezla, the first oral small molecule to be approved for psoriasis and psoriatic arthritis. ... Similarly, Novartis has enjoyed 31.7% growth thanks to another psoriasis/psoriatic

  • Pharma deals continue to slide Pharma deals continue to slide

    Pre-registration (US) topical high potency steroid for moderate to severe plaque psoriasis.

More from intelligence
Approximately 0 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Trio of Communiqué Awards for Havas Lynx

    people with moderate-to-severe psoriasis, a debilitating condition where, for many, clear skin is the goal. ... Lou Shipley, Creative Director for the campaign said: “ Using creativity to disrupt the psoriasis category and change lives for the better

  • Millefeuille

    Millefeuille. This story of hope charts Élodie’ s physical and mental struggles with psoriasis and psoriatic arthritis. ... For more information please visit http://bedrock-health.com/millefeuille/. Millefeuille. This story of hope charts Élodie’ s

  • What next for the treatment of Psoriasis in Europe?

    What next for the treatment of Psoriasis in Europe? Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe. ... Over the last decade, systemic biologic therapies for Psoriasis (PsO) have become widespread and

  • Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

    Research Partnership launches new patient Living with Psoriasis 2017 (EU) report. ... Living with Psoriasis is a study conducted amongst 615 patients in Europe.

  • Research Partnership has published a new patient Living with Psoriasis (EU) report

    Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU). ... The 7EU report has an additional 100 quantitative interviews. An attitudinal

More from PMHub
Approximately 10 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics